Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-25 Purchase |
2021-10-27 4:04 pm |
Ventyx Biosciences Inc. | VTYX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
625,000 | $16 | $10,000,000 | 1,410,303 (Indirect) |
View |
| 2021-10-13 Purchase |
2021-10-15 4:12 pm |
Pyxis Oncology Inc. | PYXS | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
450,000 | $16 | $7,200,000 | 1,118,854 (Indirect) |
View |
| 2021-09-17 Purchase |
2021-09-21 4:03 pm |
Tyra Biosciences Inc. | TYRA | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
312,500 | $16 | $5,000,000 | 1,069,932 (Indirect) |
View |
| 2021-08-03 Purchase |
2021-08-05 4:01 pm |
Immuneering Corp | IMRX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
550,000 | $15 | $8,250,000 | 2,252,628 (Indirect) |
View |
| 2021-07-20 Purchase |
2021-07-22 4:10 pm |
Erasca Inc. | ERAS | Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Asset Management LP Cormorant Private Healthcare Fund II LP Director |
950,000 | $16 | $15,200,000 | 10,672,219 (Indirect Direct) |
View |
| 2021-07-02 Purchase |
2021-07-07 4:45 pm |
Aerovate Therapeutics Inc. | AVTE | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Former 10% Owner |
500,000 | $14 | $7,000,000 | 2,030,691 (Indirect) |
View |
| 2021-06-29 Purchase |
2021-07-01 4:24 pm |
Elevation Oncology Inc. | ELEV | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
250,000 | $16 | $4,000,000 | 2,233,168 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 4:08 pm |
Monte Rosa Therapeutics Inc. | GLUE | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund II LP Former 10% Owner |
600,000 | $19 | $11,400,000 | 3,202,200 (Indirect) |
View |
| 2021-06-21 Purchase |
2021-06-23 4:02 pm |
Verve Therapeutics Inc. | VERV | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
275,000 | $19 | $5,225,000 | 984,224 (Indirect) |
View |
| 2021-04-27 Purchase |
2021-04-29 4:02 pm |
Rain Therapeutics Inc. | RAIN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund II LP Former 10% Owner |
450,000 | $17 | $7,650,000 | 2,776,657 (Indirect) |
View |
| 2021-04-20 Purchase |
2021-04-22 4:09 pm |
Biomea Fusion Inc. | BMEA | Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Asset Management LP Director |
900,000 | $17 | $15,300,000 | 3,199,783 (Indirect Direct) |
View |
| 2021-03-30 Purchase |
2021-04-01 4:15 pm |
Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
750,000 | $20 | $15,000,000 | 5,114,844 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-18 4:43 pm |
Prometheus Biosciences Inc. | RXDX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
375,000 | $19 | $7,125,000 | 2,223,022 (Indirect) |
View |
| 2020-12-18 Purchase |
2020-12-22 4:09 pm |
BioAtla Inc. | BCAB | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Former 10% Owner |
800,000 | $18 | $14,400,000 | 2,292,060 (Indirect) |
View |
| 2020-11-23 Purchase |
2020-11-23 4:59 pm |
Olema Pharmaceuticals Inc. | OLMA | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
425,000 | $19 | $8,075,000 | 3,270,544 (Indirect) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:00 pm |
Akouos Inc. | AKUS | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Former 10% Owner |
290,000 | $17 | $4,930,000 | 789,989 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion